WIL Research Selects Provantis and Centrus for Worldwide Harmonization Project

Instem Chosen by International Contract Research Organization to Replace and Enhance Toxicology Systems and Processes

CONSHOHOCKEN, PA - (BUSINESS WIRE) – May 1, 2014 - - Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that WIL Research has selected them as their exclusive non-clinical technology partner to optimize study-related processes at all WIL worldwide sites.

WIL Research has approximately 1,200 staff and 63,000 square meters of laboratory space around the world. Their facilities offer a blend of technical and regulatory expertise in discovery support, product safety toxicological research, metabolism, bioanalytical chemistry, analytical chemistry and formulation services.

“We are delighted to announce our enhanced partnership with Instem on a global level to deploy a comprehensive solution for toxicology data collection and management across our facilities situated in the United States, the Netherlands and in France,” comments David Spaight, Chief Executive Officer at WIL Research. “By leveraging our existing experience with Provantis in France, this expanded platform will support growing demand from our clients requiring a common and seamless multi-site global study management solution.”

A multi-year project, WIL Research has chosen Instem’s entire Provantis 9 software suite, including their Logbook ELN solution for paper form replacement. Instem’s Toxicology Resource Planning (“TRP”) solution is also a key element of the Provantis deployment, increasing efficiencies by enabling WIL Research to plan and manage studies and programs, allocate resources, benchmark against past studies and plan workloads for the future.

WIL Research has additionally selected Instem’s Centrus-submit™ solution to support CDISC’s Standard for Exchange of Nonclinical Data (SEND).  The submit solution suite converts data from any source system into SEND files and allows sponsors, CRO’s and regulators to share, visualize and analyze study data more efficiently.

“WIL is so much more than a client, they have turned to us as a strategic partner and we are all excited to be part of this technology-driven transformation they are embarking upon,” comments Gregor Grant, Senior Vice President at Instem. “As a leading voice for the harmonization of software solutions and consolidation of mission-critical IT providers within the life sciences, it is encouraging for us to see organizations like WIL carrying out their essential research more efficiently by using state-of-the art technology and processes to the benefit of their clients.”

Key Facts

• Instem technology to replace all existing study management systems at WIL Research
• WIL Research selects all Provantis Preclinical Study Management modules
• Using Instem’s Centrus-submit solution, WIL Research will become SEND-enabled
• WIL Research to leverage Instem’s market leading SaaS model for worldwide deployment

Provantis will be delivering demonstrable efficiency improvements to Ranbaxy at its Gurgaon R&D center in India and will offer enhanced compliance capabilities, integrated reporting and reduced QC burden.

Instem’s VP Global Sales, Europe & Asia, Neil Donaldson, commented “We are delighted to welcome Ranbaxy as our newest client in the Asia Pacific region and look forward to a long and successful partnership. Instem recognizes the increasingly important role that Indian organizations play in the global pharmaceutical market and we are committed to supporting the future growth and development of the Indian R&D community”.

Instem entered the early drug development market in India during 2005 when they welcomed their first Indian customer, Advinus Therapeutics. Instem maintains a physical presence in the region through its office in Pune.

About WIL Research

WIL Research is an interdisciplinary non-clinical contract research organization providing product safety and toxicological assessment research and services to the international pharmaceutical, biotechnology, chemical, agricultural, veterinary, food and consumer products industries.

Find out more about WIL Research at www.wilresearch.com

About Instem

Instem is a leading supplier of IT applications to the early development healthcare market, delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.

Instem’s portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.

Instem supports over 400 clients through full service offices in the United States, United Kingdom and China with additional locations in India and a full service distributor based in Japan.

Meeting clients at the intersection of investment & return™.

Press Contacts:

Instem
Gary Mitchell (US HQ)
gary.mitchell@instem.com
Tel: 610-941-0990

Julie Jones (UK HQ)
julie.jones@instem.com
Tel: +44 (0) 1785 825600